With release of Rs 166 cr of incentives under PLI scheme, Mandaviya focuses on reducing import dependency https://ift.tt/XG2Euln

The DoP launched the PLI scheme for pharmaceuticals in 2021 as part of expanding the Atma Nirbharta initiative of the government. The financial outlay under this PLI scheme is Rs 15,000 crore over a period of six years. So far, 55 applicants have been selected under the scheme, including 20 micro, small, and medium enterprises (MSMEs). The DoP has budgeted Rs 690 crore for the fiscal year 2022-2023, the first year of production for the PLI Scheme.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/R1GXBhT